News Release VacciXcell

Press Release

Singapore, December 07, 2018 - Esco Aster, a leading independent contract development and manufacturing organization dedicated to the Singapore's R&D ecosystem, has signed a research collaboration agreement with A*STAR's Institute of Molecular Cell Biology (IMCB). The collaboration will facilitate the quick development and commercialisation of a multivalent vaccine targeting Hand Foot and Mouth Disease (HFMD).

Dimension Attention

Dec 04, 2017

Therapeutic application of cells or cell-based therapy is a flourishing research field that offers a transformative approach to the healthcare industry. This type of research provides hope not only for treating incurable or rare diseases, but also the possibility to cure them. For the manufacture of cell-based therapies, cells are optimized to produce therapeutic agents. Generating an adequate number of cells with retained cell function and quality represents an essential factor for product effi

Read More

World Vaccine and Immunotherapy Congress | Coronado Bay Resort San Diego, CA

Nov 30, 2017

VacciXcell will unveil the new and improved TideCell®, a revolutionary bioprocessing adherent bioreactor, which utilizes the tide motion principle for the upcoming World Vaccine and Immunotherapy Congress. This event will give an in-depth look at the advancements in the integration of innovative technologies and its impact on immunotherapy and vaccine development.

Read More

Imagine the Possibilities: From Science to Society

Nov 08, 2017

VacciXcell is strengthening its core in bioprocessing for being one of the exhibitors of the upcoming Research Support Center Scientific Roadshow on November 14, 2017, starting from 9:30 am to 3:30 pm at Epicenter Matrix Biopolis, Singapore.

Read More

Continuous Bioprocessing

Oct 23, 2017

Biomanufacturing companies have long sought better approaches with regards to bioprocessing. Due to rapidly fluctuating market demands for biologics, there is a growing interest in the benefits of continuous bioprocessing, mainly for cell culture. This process had increasingly driven biomanufacturing companies to develop innovative solutions for highly flexible and cost-effective production.

Read More

Esco VacciXcell at World Vaccine Congress in Barcelona, Spain

Oct 20, 2017

Esco VacciXcell recently participated in the World Vaccine Congress Exhibition held in Crown Plaza Hotel Barcelona, Spain from October 10-12, 2017. The congress brought together scientific scope, breadth, and partners from around the globe.

Read More

Esco Life Sciences and Healthcare is Strengthening its Core in Biocontainment

Oct 12, 2017

From the world’s most certified Biological Safety Cabinet manufacturer, Esco is now the only manufacturer of biocontainment solutions with vertically integrated and regional factories to provide customized Class III Biological Safety Cabinets which exceed international standards from NSF 49 to EN 12469.

Read More

Esco VacciXcell Heads to the East!

Oct 05, 2017

Esco VacciXcell have recently participated in BioProcess International Conference and Exhibition 2017 last September 26-28 in Hynes Convention Center Boston, Massachusetts. The event brought science, technology, and partners to accelerate promising biologics towards commercial success.

Read More

Esco VacciXcell is Launching the New and Improved TideCell in the US

Sep 26, 2017

Esco VacciXcell is proud to launch the new TideCell® with enhanced features and now controlled by Siemens HMI/PLC in USA soil.

Read More

Stop POLIOMYELITIS Get Vaccinated

Sep 14, 2017

Poliomyelitis also known as Polio or infantile paralysis, is a highly contagious viral infection caused by poliovirus. It invades the nervous system and can cause irreversible paralysis, breathing problems and even death. It is caused by one of the three polioviruses from genus Enterovirus: Human poliovirus 1 (HPV1), Human poliovirus 2 (HPV2) and Human poliovirus 3 (HPV 3). Polio can strike at any age, but mainly affects children under 5 years old.

Read More

Esco Vaccixcell at International Society for Pharmaceutical Engineering (ISPE) 2017

Aug 29, 2017

The International Society for Pharmaceutical Engineering or ISPE was successfully concluded last August 23-26, 2017 at Suntec & Exhibition Centre in Singapore. This year’s theme “Innovating for Next Generation Pharma Manufacturing” involved a lot of bioprocessing companies and delegates from different companies around the Globe.

Read More

GlucCell: Your Glucose Meter Partner

Aug 10, 2017

Glucose is the main source of energy for cells specially in in-vitro cultures. Glucose gives cells the required energy in order to grow and proliferate. Sadly reserchers and scientists around the globe do not know the proper levels of glucose required by their culture. Learn why measuring glucose is important and what is the best way to do it.

Read More

CPhI China 2017

Jul 14, 2017

CPhI China brings together domestic and international pharmaceutical  companies every year to share ideas and innovations in China. LABWorld China 2017, in partnership with CPhI, is a grand exhibition held at the New International Expo Center, N1, Shanghai, China.

Read More

Man's Best Friend and Rabies

Jul 01, 2017

Rabies is a disease caused by a rabies virus of the genus Lyssavirus. It is most often transmitted from a bite of a rabid animal. The virus replicates in the animal carrying it and is retained in their salivary glands. Although dogs are commonly known to transmit rabies; skunks, bats, racoons, and foxes are among the animals that are reported to transmit vast majority of rabies cases. It is endemic on all continents except Antartica.

Read More

Introducing Aster BioPharma Contract Development and Manufacturing Organization (CDMO)

Jun 15, 2017

A CDMO or Contract Development and Manufacturing Organization is a contractual company that provides services like drug development and drug manufacturing in the healthcare industry. CDMO services running on Esco's VacciXcell are now provided by a new independent company called Esco Aster Biopharma.

Read More


Jun 14, 2017

Esco VacciXcell attended the recently concluded human vaccine and veterinary industry summit held in Four Points Hotel, Qing Dao, West Coast China. The event lasted 2 days, starting from June 13 and ending on June 14, 2017. The event commemorated two both the 9th Human Vaccine Industry Summit and the 5th Veterinary Industry Summit.

Read More

Do not let Yellow Fever ruin Summer

May 11, 2017

Planning for a vacation to that tropical paradise? Aside from having your plane ticket, hotel and itinerary ready maybe you should also consider getting vaccinated for yellow fever. Do not let yellow ruin your summer!

Read More

ISCT 2017

May 08, 2017

VacciXcell participated in the recently concluded ISCT 2017 held at ExCel London, United Kingdom last May 3-6, 2017. ISCT 2017 marks the 25th Anniversary of the International Society for Cellular Therapy. VacciXcell displayed their tide motion bioreactor systems which are perfect for cell proliferation such as those utilized in cellular therapy.

Read More

Korea Lab 2017

Apr 24, 2017

Esco VacciXcell participated in the recently concluded Korea Lab 2017 held last April 18-21, 2017 at Korea International Convention Center, Gyeonggi, South Korea. The event was attended mostly by professionals from the pharmaceutical, cell therapy and cosmetics industry.

Read More

Why Wave When You Can Tide

Apr 21, 2017

Tide motion is a novel and innovative system for high density culture of adherent cells. Learn why tide motion can solve all your adherent culture problems!

Read More

VacciXcell at World Vaccine Congress 2017

Apr 13, 2017

World Vaccine Congress USA successfully concluded another series last April 10-12, 2017 held at Grand Hyatt Washington DC. This year, the Congress brought together over 700 senior vaccine executives for debates and discussions exploring new vaccine technologies.

Read More

Understanding Vaccines: Attenuated vs Inactivated

Mar 17, 2017

Attenuated vaccines contain live viruses albeit "weakened". These viruses live such that they can induce an immune response but not strong enough to cause disease to the host. Inactivated vaccines contain inactive or "killed" viruses. The viruses were inactivated using either chemical or physical processes but retain their composition thus still allowing them to induce an immune response.

Read More

Know Why Industries are Going with the New Tide

Mar 08, 2017

Cell culture using mammalian cells has been used in bioprocessing and biopharmaceutical to produce a variety of life saving products. Mammalian cells are preferred by scientists and industries due to its relatively closer resemblance to human cells as compared to microbial, plants or insect cells. The challenge of using mammalian cells however has always been in the culture and proliferation of the cells.

Read More

BioProcess International West 2017

Feb 28, 2017

Esco VacciXcell joined the only phase-based event to break down silos for accelerating biologics from early stage process development to commercial manufacturing in the western United States!

Read More


Feb 15, 2017

Avian influenza, also known as avian flu or bird flu, is a type A influenza caused by viral infection in birds. Generally speaking, avian flu can only infect birds and poultry but there has been cases wherein humans were infected through direct or indirect contact with infected birds. Notable subtypes of avian flu are H5N1 and H7N9

Read More

Innovations and Advances for Bioprocessing Seminar, Hong Kong

Feb 01, 2017

Esco VacciXcell successfully conducted a seminar last January 20, 2017 in HKPC Building, 78 Tat Chee Aveneu, Kowloon Tong, Hong Kong. Lead by Mr. Liang Ke, product specialist, and Ms. MK Kim, application specialist, the seminar entitled "Innovations and Advances for Bioprocessing" welcomed attendees to a day of learning on the new technologies and processes on bioprocessing, specifically in the field of cell therapy.

Read More


Jan 27, 2017

In 2009, the H1N1 pandemic was bringing panic to the whole world due to its infection rate and lethality. In response to this threat, Medigen Biotechnology Corporation (MBC) decided to create a vaccine division which would integrate innovative technology that would be able to produce necessary vaccines in large volumes within a short period of time.

Read More


Jan 17, 2017

During in-vitro cell culture, it is important that the culture environment mimic the chosen cell line's original in-vivo environment for it to grow and propagate. Glucose, being the main source of energy for heterotrophic cells, is one of the parameters that should be carefully monitored during the culturing process.

Read More

CPhI and P-MEC India 2016

Nov 25, 2016

Esco VacciXcell alongside Esco Biotech (India) Pvt. Ltd. Participated in the recently concluded CPhI-India and P-MEC held last November 21 - 23, 2016 at MMRDA Grounds, BKC in Mumbai, India.

Read More


Nov 14, 2016

Esco VacciXcell has conducted two seminars within the past few months that is aimed to educate and enlighten people from the scientific community of the revolutionary technology that is the TideMotion bioreactor system.

Read More

Catching the Tide: How VacciXcell's TideMotion Bioreactor is Innovating Bioprocessing

Nov 08, 2016

Biopharmaceutical companies and industries around the world use cell culture as a means of producing their bio products. Whether the company is producing vaccines, monoclonal anti-bodies, proteins, biosimilars or stem cells, using some type of bioreactor is the widely accepted and most efficient method of doing it.

Read More

VacciXcell at the AAVLD/USAHA Annual Meeting 2016

Oct 25, 2016

The American Association of Veterinary Laboratory Diagnosticians (AAVLD) and the United States Animal Health Association (USAHA) held their 59th and 120th annual meetings, respectively, at Sheraton Greensboro, North Carolina last October 13-19, 2016. The meeting was well attended by both members and non-members of both associations.

Read More

VacciXcell™ Hybrid Bioreactor

Oct 21, 2016

Biopharmaceuticals are therapeutics derived from biological sources; they are a promising and growing trend in the treatment of diseases. In contrast to their synthetic counterparts, biopharmaceuticals are much more specific and targeted and therefore have fewer side effects. Furthermore, they do not merely treat the symptoms of diseases but can treat the diseases at their cause.

Read More

Go with the Tide: ISCT North America Regional Meeting 2016 & Boston Biotech Week Exhibits

Oct 14, 2016

The International Society of Cell Therapy held its annual North America Regional Meeting at the Peabody in Memphis, Tennessee last September 30 to October 2. The event was well attended by experts in the field of Cell Therapy such as medical doctors, clinicians, scientists, regulatory experts, and laboratory professionals and industry personnel involved in cell processing facilities and programs in North America.

Read More


Sep 29, 2016

Europe's most successful vaccine event is now entering its 17th year. For 16 years the World Vaccine Congress in Europe has been the leading event to talk about scientific advances and find new business opportunities within the vaccine sector and this year is no exception.

Read More


Sep 07, 2016

The 2016 International Society of Pharmaceutical (ISPE) conference held at the Suntec Convention and Exhibition Center in Singapore has concluded last August 26 with more than 100 local and international companies participating in the event.

Read More

VacciXcell conducts product training for International Atomic Energy Agency

Aug 12, 2016

Dr. Mudasser Habib, is a principal scientist whose research focuses on the development of vaccine for PPR virus for goat cells has participated in a product training for CelCradle™, TideCell™ and StirCradle™, bioreactors conducted by the VacciXcell Esco Healthcare last August 1-12, 2016 at the Esco Ventures, Singapore.

Read More

VacciXcell™ Hybrid Bioreactor

Aug 10, 2016

Biopharmaceuticals are therapeutics derived from biological sources; they are a promising and growing trend in the treatment of diseases. In contrast to their synthetic counterparts, biopharmaceuticals are much more specific and targeted and therefore have fewer side effects.

Read More

The International Society of Cellular Therapy (ISCT) 2016

Jun 01, 2016

VacciXcell was recently at The International Society of Cellular Therapy (ISCT) in Singapore. Held at the Suntec Convention and Exhibition Centre, the 22nd Annual Scientific Meeting was held in Asia for the first time.

Read More

Vaccine BioProcessing Seminar

May 25, 2016

One of VacciXcell’s main visions is a world of vaccine self-sufficiency for all nations, including developing ones and conducting free end-user seminars is one of VacciXcell’s ways to fulfil this vision. These end-user seminars help increase awareness of current news and situations in the vaccine industry and as well as the latest trends and techniques in vaccine bioprocessing;

Read More

Introducing the Esco TideCell®

May 06, 2016

VacciXcell’s TideCell® System takes vaccine production to a higher level, with new enhanced features and more options for better flexibility. Users can choose between single-use and multiple-use and different capacities and options for the different components of the TideCell® system.

Read More

Zoonotic Outbreaks: The VacciXcell Solution

May 02, 2016

When an animal epidemic breaks out, the economy suffers grave losses due to agricultural losses, as the infected animals can die or their meat, milk, and other products are no longer fit for human consumption. Moreover, sanitation and immunization in farms are not well established and thus, diseases can easily spread among the herd, leading to further losses.

Read More

World Vaccine Congress USA 2016

Apr 04, 2016

VacciXcell was present at the recently concluded World Vaccine Congress USA 2016 held at the Grand Hyatt Washington DC. The Congress, which ran for 3 days, consisted of 7 conferences namely World Vaccine Cancer & Immunotherapy, World Vaccine Influenza & Respiratory, World Vaccine Emerging & Re-Imerging, World Vaccine Clinical Trials, World Vaccine Bioprocessing & Manufacturing, World Vaccine Veterinary, and World Vaccine Partnerships.

Read More

Esco VacciXcell commences the first day of World Vaccine Congress USA 2016 in Washington DC

Mar 29, 2016

For the first time, our production scale packed bed 2 liter bioreactor, with pH and DO control, was displayed and launched in the American market, drawing huge attention and positive feedback from various delegates.

Read More

Arab Lab 2016

Mar 24, 2016

VacciXcell, together with Esco, visited Dubai again for the second time this year to attend Arab Lab 2016, which was held last 20-23 March 2016 at the Dubai World Trade Center. VacciXcell reintroduced the CelCradle™ to the Middle East, this time brining the unit to the exhibition.

Read More

Zika Virus and Pandemic Outbreaks: The VacciXcell Solution

Mar 18, 2016

In September 2012, the first case of the deadly Mers-Cov virus was reported in the Middle East and has since then spread within the Arabian Peninsula. In 2015, the largest Mers-Cov outbreak outside the Arabian Peninsula occurred in South Korea. According to WHO, there is a total of 591 Mers-Cov related deaths since 2012 among the 1652 reported cases in 26 countries around the world.

Read More

VacciXcell coming to you in Middle East!

Jan 29, 2016

VacciXcell is currently in Dubai with the Esco Group of Companies exhibiting our innovative CelCradle Biorea

Read More

Innovative cold chain solution from VacciXcell

Dec 16, 2015

VacciXcell is proud to be awarded a walk in chiller project for a developing country for vaccine storage.

Read More

VacciXcell commences the 1st day of exhibition at the Europe Vaccine Congress 2015 in Madrid

Nov 10, 2015

VacciXcell, a subsidiary of Esco Group of companies, completes day 1 of the European Vaccine Congress. Of great interest is our latest CelCradle Single-Use Bioreactor that drew large responses from the international delegates.

Read More

Esco Launches VacciXcell and TapestleRx

Nov 10, 2015

Esco group of companies is excited to launch 2 new platforms VacciXcell and TaPestle Rx!

Read More

9th Vaccine & ISV Congress

Oct 28, 2015

VacciXcell exhibited at the 9th Vaccine & ISV Congress held on 18-20th October at Lotte Hotel in Seoul, Korea. Products featured at the booth were the BelloCell® bioreactor system and the CelSafe® CO2 Incubator, which is an excellent combination for vaccine development.

Read More

Official Launch of VacciXcell at World Vaccine Congress Asia

Jun 10, 2015

VacciXcell officially launched in Singapore on 3-4 June, 2015 at Suntec Convention and Exhibition Centre during World Vaccine Congress Asia! We are excited to embark on this journey with you, offering turnkey solutions to clients of all applications and budgets.

Read More